{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:27Z","timestamp":1790803287054,"version":"4.1.0"},"reference-count":77,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a recently introduced term for steatotic liver disease (SLD). Although the inflammatory process is central to the pathogenesis of SLD, research investigating the differences in systemic inflammation across various SLD subtypes as well as sex differences is limited. This population-based, cross-sectional study investigated the association between SLD subtypes and high-sensitivity C-reactive protein (hs-CRP) levels among Korean adults (N = 20,141; mean age: 50.8 \u00b1 16.7 years). The participants were classified into five groups that included no SLD, MASLD, metabolic alcohol-associated liver disease (MetALD), alcoholic liver disease with metabolic dysfunction (ALD with MD), and other SLDs. The median (Q1, Q3) value of the hs-CRP level was 0.54 mg\/L (0.33, 1.04). Among men, compared to levels in the no SLD group, the MASLD, MetALD, and ALD with MD groups were associated with 41.9% (95% confidence interval [CI]: 35.1\u201349.1%), 46.8% (95% CI: 35.0\u201359.6%), and 51.8% (95% CI: 30.0\u201377.2%) increases in hs-CRP levels, respectively. The association between SLD subtypes and hs-CRP levels was stronger among women, and compared to the levels in the no SLD group, the MASLD, MetALD, and ALD with MD groups were associated with 81.5% (95% CI: 73.6\u201389.8%), 84.3% (95% CI: 58.1\u2013114.8%), and 98.2% (95% CI: 38.0\u2013184.8%) increases in hs-CRP levels, respectively. In conclusion, our findings indicate a varying profile of systemic inflammation across SLD subtypes, with more pronounced increases in hs-CRP levels in women with SLDs.<\/jats:p>","DOI":"10.3390\/biom14111468","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T13:03:14Z","timestamp":1731934994000},"page":"1468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-8326","authenticated-orcid":false,"given":"Seong-Uk","family":"Baek","sequence":"first","affiliation":[{"name":"Graduate School, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ha","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"},{"name":"The Institute for Occupational Health, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101526","DOI":"10.1016\/j.clinre.2020.06.022","article-title":"Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea","volume":"45","author":"Im","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3349\/ymj.2022.0332","article-title":"Liver Diseases in South Korea: A Pulse Check of the Public\u2019s Knowledge, Awareness, and Behaviors","volume":"63","author":"Lee","year":"2022","journal-title":"Yonsei Med. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3349\/ymj.2022.0540","article-title":"Changes in the Prevalences of Obesity, Abdominal Obesity, and Non-Alcoholic Fatty Liver Disease among Korean Children during the COVID-19 Outbreak","volume":"64","author":"Song","year":"2023","journal-title":"Yonsei Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lee, N.H., Jeong, S.J., Wang, J.H., Choi, Y.J., Oh, H.M., Cho, J.H., Ahn, Y.C., and Son, C.G. (2023). The Clinical Diagnosis-Based Nationwide Epidemiology of Metabolic Dysfunction-Associated Liver Disease in Korea. J. Clin. Med., 12.","DOI":"10.3390\/jcm12247634"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4093\/dmj.2022.0444","article-title":"Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017","volume":"47","author":"Han","year":"2023","journal-title":"Diabetes Metab. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review","volume":"32","author":"Chan","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, and European Association for the Study of Obesity (2024). EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Obes. Facts, 17, 374\u2013444.","DOI":"10.1159\/000539371"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","article-title":"Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: An analysis of data from a prospective cohort study","volume":"9","author":"Israelsen","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Oh, R., Kim, S., Cho, S.H., Kim, J., Lee, Y.B., Jin, S.M., Hur, K.Y., Kim, G., and Kim, J.H. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality. Diabetes Metab. J.","DOI":"10.4093\/dmj.2024.0042"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3803\/EnM.2024.103","article-title":"No More NAFLD: The Term Is Now MASLD","volume":"39","author":"Bae","year":"2024","journal-title":"Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jhep.2023.09.035","article-title":"Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes","volume":"80","author":"He","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cac2.12454","article-title":"Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: A population-based cohort study with 9.7 million Korean subjects","volume":"43","author":"Chung","year":"2023","journal-title":"Cancer Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.numecd.2023.01.013","article-title":"Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study","volume":"33","author":"Yoo","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/liv.15508","article-title":"Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease","volume":"43","author":"Chun","year":"2023","journal-title":"Liver Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Corrao, S., Calvo, L., Gran\u00e0, W., Scibetta, S., Mirarchi, L., Amodeo, S., Falcone, F., and Argano, C. (2024). Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future. Nutr. Metab. Cardiovasc. Dis., in press.","DOI":"10.1016\/j.numecd.2024.07.019"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mladenic, K., Lenartic, M., Marinovic, S., Polic, B., and Wensveen, F.M. (2024). The \u201cDomino effect\u201d in MASLD: The inflammatory cascade of steatohepatitis. Eur. J. Immunol., 54.","DOI":"10.1002\/eji.202149641"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.aohep.2024.101491","article-title":"Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database","volume":"29","author":"Nemer","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7762\/cnr.2020.9.3.182","article-title":"Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver","volume":"9","author":"Lim","year":"2020","journal-title":"Clin. Nutr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Duan, Y., Pan, X., Luo, J., Xiao, X., Li, J., Bestman, P.L., and Luo, M. (2022). Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.880298"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1074\/jbc.271.16.9503","article-title":"STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ding, Z., Wei, Y., Peng, J., Wang, S., Chen, G., and Sun, J. (2023). The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102711"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Coste, S.C., Or\u0103\u0219an, O.H., Cozma, A., Negrean, V., Sitar-T\u0103ut, A.V., Filip, G.A., Hangan, A.C., Lucaciu, R.L., Iancu, M., and Procopciuc, L.M. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease: The Associations between Inflammatory Markers, TLR4, and Cytokines IL-17A\/F, and Their Connections to the Degree of Steatosis and the Risk of Fibrosis. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092144"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Amezcua-Castillo, E., Gonzalez-Pacheco, H., Saenz-San Martin, A., Mendez-Ocampo, P., Gutierrez-Moctezuma, I., Masso, F., Sierra-Lara, D., Springall, R., Rodriguez, E., and Arias-Mendoza, A. (2023). C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease-Advancing toward Precision Medicine. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092444"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/01.CIR.0000093381.57779.67","article-title":"Cardiology Patient Page. C-reactive protein: A simple test to help predict risk of heart attack and stroke","volume":"108","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sandireddy, R., Sakthivel, S., Gupta, P., Behari, J., Tripathi, M., and Singh, B.K. (2024). Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1433857"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.clinbiochem.2010.09.003","article-title":"The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population","volume":"43","author":"Chiang","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.2147\/JIR.S466469","article-title":"Association of Hematological Biomarkers of Inflammation with 10-Year Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: The ARIC Study","volume":"17","author":"Wang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wan, H., Gui, Z., Liu, L., Wang, N., and Shen, J. (2024). Hs-CRP and HOMA-IR: Include them in the MASLD definition, or treat them as mediators between MASLD and atherosclerotic cardiovascular disease?. J. Hepatol., 81.","DOI":"10.1016\/j.jhep.2024.08.005"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.12998\/wjcc.v10.i5.1457","article-title":"Nonalcoholic fatty liver disease shows significant sex dimorphism","volume":"10","author":"Chen","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Koceva, A., Herman, R., Janez, A., Rakusa, M., and Jensterle, M. (2024). Sex- and Gender-Related Differences in Obesity: From Pathophysiological Mechanisms to Clinical Implications. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137342"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cherubini, A., Della Torre, S., Pelusi, S., and Valenti, L. (2024). Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends Mol. Med.","DOI":"10.1016\/j.molmed.2024.05.013"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Joo, S.K., and Kim, W. (2024). Sex differences in metabolic dysfunction-associated steatotic liver disease: A narrative review. Ewha Med. J., 47.","DOI":"10.12771\/emj.2024.e17"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/gastro\/gou034","article-title":"Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease","volume":"2","author":"Tapper","year":"2014","journal-title":"Gastroenterol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","article-title":"Ethnicity and nonalcoholic fatty liver disease","volume":"55","author":"Bambha","year":"2012","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s10620-007-0074-0","article-title":"Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis","volume":"53","author":"Singh","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MEG.0000000000000151","article-title":"Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China","volume":"26","author":"Wang","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.jhep.2023.08.013","article-title":"Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: Biological sex matters","volume":"80","author":"Ji","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ije\/dyt228","article-title":"Data resource profile: The Korea National Health and Nutrition Examination Survey (KNHANES)","volume":"43","author":"Kweon","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Oh, K., Kim, Y., Kweon, S., Kim, S., Yun, S., Park, S., Lee, Y.K., Kim, Y., Park, O., and Jeong, E.K. (2021). Korea National Health and Nutrition Examination Survey, 20th anniversary: Accomplishments and future directions. Epidemiol. Health, 43.","DOI":"10.4178\/epih.e2021025"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Miwa, T., Tajirika, S., Imamura, N., Adachi, M., Horita, R., Hanai, T., Ng, C.H., Siddiqui, M.S., Fukao, T., and Shimizu, M. (2024). Usefulness of health checkup-based indices in identifying metabolic dysfunction-associated steatotic liver disease. JGH Open, 8.","DOI":"10.1002\/jgh3.13110"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mahachai, N., Washirasaksiri, C., Ariyakunaphan, P., Kositamongkol, C., Sitasuwan, T., Tinmanee, R., Auesomwang, C., Sayabovorn, N., Chaisathaphol, T., and Phisalprapa, P. (2023). Clinical Predictive Score for Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals with Prediabetes Using Transient Elastography. J. Clin. Med., 12.","DOI":"10.3390\/jcm12247617"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD","volume":"13","author":"Abdelhameed","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101497","DOI":"10.1016\/j.diabet.2023.101497","article-title":"MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus","volume":"50","author":"Mantovani","year":"2024","journal-title":"Diabetes Metab."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Banait, T., Wanjari, A., Danade, V., Banait, S., and Jain, J. (2022). Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review. Cureus, 14.","DOI":"10.7759\/cureus.30225"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1757975919854301","article-title":"Development of the Korean Global Physical Activity Questionnaire: Reliability and validity study","volume":"27","author":"Lee","year":"2020","journal-title":"Glob. Health Promot."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/heartjnl-2018-314216","article-title":"Inflammation markers and risk of developing hypertension: A meta-analysis of cohort studies","volume":"105","author":"Jayedi","year":"2019","journal-title":"Heart"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Yang, X., Tao, S., Peng, J., Zhao, J., Li, S., Wu, N., Wen, Y., Xue, Q., Yang, C.X., and Pan, X.F. (2021). High-sensitivity C-reactive protein and risk of type 2 diabetes: A nationwide cohort study and updated meta-analysis. Diabetes Metab. Res. Rev., 37.","DOI":"10.1002\/dmrr.3446"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/obr.12003","article-title":"Obesity and C-reactive protein in various populations: A systematic review and meta-analysis","volume":"14","author":"Choi","year":"2013","journal-title":"Obes. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.clnu.2024.05.042","article-title":"Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial","volume":"43","author":"Milagro","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chen, S., Tian, C., Wang, Q., Yang, Z., Che, W., Li, Y., and Luo, Y. (2024). Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study of NHANES 2007-2018. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1415484"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Jeong, Y., Lee, B.J., Hur, W., Lee, M., and Han, S.H. (2024). Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study. Metabolites, 14.","DOI":"10.3390\/metabo14070371"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/jfmpc.jfmpc_887_19","article-title":"Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: A cross-sectional study","volume":"9","author":"Kumar","year":"2020","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41043-023-00372-8","article-title":"Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity","volume":"42","author":"Jamialahmadi","year":"2023","journal-title":"J. Health Popul. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41575-024-00990-5","article-title":"MASLD: A disease in flux","volume":"21","author":"Allen","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Yu, L., Gao, F., Li, Y., Su, D., Han, L., Li, Y., Zhang, X., and Feng, Z. (2024). Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications. Biomed. Pharmacother., 175.","DOI":"10.1016\/j.biopha.2024.116724"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Okekunle, A.P., Youn, J., Song, S., Chung, G.E., Yang, S.Y., Kim, Y.S., and Lee, J.E. (2023). Predicted pro-inflammatory hs-CRP score and non-alcoholic fatty liver disease. Gastroenterol. Rep., 11.","DOI":"10.1093\/gastro\/goad059"},{"key":"ref_66","first-page":"166","article-title":"Association between the Severity of Nonalcoholic Fatty Liver Disease and High Sensitivity C-reactive Protein in Adults","volume":"21","author":"Yeo","year":"2012","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.18632\/oncotarget.7401","article-title":"Parabolic relationship between sex-specific serum high sensitive C reactive protein and non-alcoholic fatty liver disease in Chinese adults: A large population-based study","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11892-018-1031-3","article-title":"Gender and Sex Differences in Adipose Tissue","volume":"18","author":"Chang","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: Structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1440-1746.2000.02226.x","article-title":"Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution","volume":"15","author":"Lonardo","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/ajcn\/nqac059","article-title":"Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population","volume":"115","author":"Ciardullo","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"200210","DOI":"10.1016\/j.hnm.2023.200210","article-title":"Visceral fat: A key mediator of NAFLD development and progression","volume":"33","author":"Bansal","year":"2023","journal-title":"Hum. Nutr. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"100835","DOI":"10.1016\/j.jhepr.2023.100835","article-title":"Non-alcoholic fatty liver disease in women\u2014Current knowledge and emerging concepts","volume":"5","author":"Eng","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.3350\/cmh.2022.0362","article-title":"Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments","volume":"29","author":"Ahn","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Biciusca, T., Stan, S.I., Balteanu, M.A., Cioboata, R., Ghenea, A.E., Danoiu, S., Bumbea, A.M., and Biciusca, V. (2023). The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13213316"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1210\/clinem\/dgad586","article-title":"Noninvasive Indices of MASLD Are Associated with Hypogonadism in Male Patients With Type 2 Diabetes Mellitus","volume":"109","author":"Caretta","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/11\/1468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:34:43Z","timestamp":1760114083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/11\/1468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["biom14111468"],"URL":"https:\/\/doi.org\/10.3390\/biom14111468","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]}}}